Thick primary melanoma has a heterogeneous tumor biology: an institutional series - Wikidata - wikimedia - TriplyDB

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

http://www.wikidata.org/entity/Q34957433

about

Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.Sentinel lymph node biopsy in patients with thick primary cutaneous melanoma: patterns of use and underuse utilizing a population-based model.Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single-Institution Experience and Literature Meta-Analysis.Metastatic Melanoma in Sentinel Node-Negative Patients: The Ottawa Experience.

P2860

Q36356155-350CAF37-4B73-455B-B402-C345A29A2C7D Q36566045-CC078CD5-06DB-459C-938A-6CF9B056E260 Q38526523-73C827AD-74E9-4823-AAD4-B00685C6456A Q47744033-771CDC37-1868-499B-ABCC-90D5542EC43D Q50540269-E30DA518-5BA3-4C12-802F-56927CE5872D

P2860

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

http://www.wikidata.org/entity/Q34957433

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@ast

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@en

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@nl

type

label

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@ast

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@en

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@nl

prefLabel

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@ast

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@en

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@nl

P1433

Q34957433-CE15C0E6-81D8-458D-A4E1-89B4B6162A4A

P1476

Q34957433-EFA85053-1C47-489C-A632-C782F4EB45E9

P2093

Q34957433-24725D8E-62DE-42D8-BBEF-CDEF986CA493

Q34957433-923BA0FA-1116-44DF-8195-8E3CF096D10D

Q34957433-AAD2FD34-D8F1-4ADE-A35F-B00200B75A80

Q34957433-AB7C6FDC-980D-414C-9D8C-5F9138EFADA1

Q34957433-BA89FDA4-F116-4675-9007-2B36DE8961A0

Q34957433-DDCC02D4-DEEC-421E-8BC5-9B6CE9C8E2D2

P2860

Q34957433-03A67266-E2E9-418F-B077-A5CFA94B8B02

Q34957433-0E0F45EF-2F6C-4A96-8425-BF4E5290EB13

Q34957433-13461CB3-F86A-4217-879F-918D21B1D84C

Q34957433-138BC40B-94B8-4A1C-940F-7C8CB9BE3119

Q34957433-3B4BA704-C31A-4961-ABA8-56C39AC7FB4D

Q34957433-43B380DC-E9A6-4300-8F06-FA00A4066F77

Q34957433-45354A67-7659-4508-AD2D-3B9FC55F2563

Q34957433-4C4AB4BB-800E-4FF8-8CEB-0F3AB43510FA

Q34957433-50214AD8-D9E7-40A6-BCCA-00B5F8B0B120

Q34957433-5673A9D1-2CC2-471A-BCCF-6244E39DE73E

P2888

Q34957433-D7D1A617-860F-4852-955D-CF250545038E

P304

Q34957433-E6979184-2A6F-40C4-A999-FBF05B166AF7

P31

Q34957433-8BF49180-BDF9-44B3-BFB3-CF69B92FC5A9

P356

Q34957433-E8FA7B3C-FA45-4CFE-BC19-5E60A1FFB650

P478

Q34957433-1F836C2B-F41F-428C-8A92-352D6B704ED4

P50

Q34957433-CC915677-177F-4CB8-92DB-0EA7D4D3571B

P577

Q34957433-D3E81ABA-971D-4D7E-A5E3-4DC3FA934DFF

P5875

Q34957433-B70DA374-4ED4-4AC7-9148-E29AA95F71EC

P6179

Q34957433-5D9291AF-15AD-42AF-A2D1-B9364B8DC218

P698

Q34957433-84E93078-B571-46A3-A302-A74BF9DC79D6

P932

Q34957433-197F60AE-690C-45E0-BF7C-080838DEFB81

P356

P1433

World Journal of Surgical Oncology

P1476

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

@en

P2093

Ari-Nareg Meguerditchian

http://www.w3.org/2001/XMLSchema#string

Bethany Lema

http://www.w3.org/2001/XMLSchema#string

Calvin Young

http://www.w3.org/2001/XMLSchema#string

Gregory Wilding

http://www.w3.org/2001/XMLSchema#string

John M Kane

http://www.w3.org/2001/XMLSchema#string

Kobby Asubonteng

http://www.w3.org/2001/XMLSchema#string

P2860

Final version of 2009 AJCC melanoma staging and classification

Prognosis of thick cutaneous melanoma.

Increasing burden of melanoma in the United States.

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Sentinel-node biopsy or nodal observation in melanoma.

Sentinel lymph node mapping for thick (>or=4-mm) melanoma: should we be doing it?

Surgical procedures and lymphedema of the upper and lower extremity.

P2888

P304

40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7819-9-40

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Ari-Nareg Meguerditchian

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51050756

http://www.w3.org/2001/XMLSchema#string

P6179

1038775839

http://www.w3.org/2001/XMLSchema#string

P698

21492474

http://www.w3.org/2001/XMLSchema#string

P932

3090362

http://www.w3.org/2001/XMLSchema#string